Guardian Pharmacy Services, Inc. (GRDN) Stock Price & Analysis
Guardian Pharmacy Services, Inc. (GRDN) rose 1.59% to USD 40.77 as of September 8, 2026 at 07:34 UTC, according to Nexqual real-time market data.
GRDN last closed at USD 40.13; the session ranged USD 39.98–40.95 on volume of 418,369 shares. Market capitalization is $2.58B, with a 52-week range of USD 23.14–47.02 (NYQ). Source: Nexqual, September 8, 2026 at 07:34 UTC.
Key Statistics (as of September 8, 2026 at 07:34 UTC)
| Price | USD 40.77 |
|---|---|
| Change | ▲ 1.59% (up) |
| Previous Close | USD 40.13 |
| Open | USD 40.13 |
| Day Range | USD 39.98 – 40.95 |
| 52-Week Range | USD 23.14 – 47.02 |
| Volume | 418,369 shares |
| Market Cap | $2.58B |
| Exchange | NYQ |
Technical Analysis (GRDN)
Nexqual's technical model rates GRDN "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 07:34 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.8 (neutral) |
| vs SMA50 | Above (USD 39.85) |
| MACD | -0.16 (negative) |
Analyst Ratings (GRDN)
Wall Street analysts rate GRDN "Strong Buy" based on 6 analysts, with a mean price target of USD 48.83 (range USD 47–50), per Nexqual as of September 8, 2026 at 07:34 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 48.83 |
| High Target | USD 50 |
| Low Target | USD 47 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (GRDN)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD 0.32 |
| Revenue Estimate | $365.84M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.29 vs est 0.26 ▲ beat |
| 2026-03-31 | USD 0.29 vs est 0.24 ▲ beat |
| 2025-12-31 | USD 0.37 vs est 0.27 ▲ beat |
| 2025-09-30 | USD 0.25 vs est 0.24 ▲ beat |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Financials & Fundamentals (GRDN)
| Total Revenue | $1.46B |
|---|---|
| Revenue Growth (YoY) | +2.20% |
| Gross Margin | +21.63% |
| Operating Margin | +3.48% |
| Profit Margin | +4.50% |
| ROE | +30.42% |
| Debt / Equity | 15.24 |
| Current Ratio | 1.65 |
| Total Cash | $89.81M |
| Total Debt | $39.27M |
| Free Cash Flow | $64.55M |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Financial Health Score (GRDN)
Nexqual rates Guardian Pharmacy Services, Inc.'s overall financial health "Solid" across five dimensions, as of September 8, 2026 at 07:34 UTC.
| Growth | Strong — Revenue +18% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 22%, operating 3% |
| Balance Sheet | Strong — $90M cash vs $39M debt, net cash position |
| Cash Flow | Mixed — FCF $65M, slim 4.5% margin |
| Efficiency | Strong — ROE 30%, ROA 13.4% |
Ownership (GRDN)
| Insider Ownership | +37.51% |
|---|---|
| Institutional Ownership | +60.72% |
| Shares Outstanding | 49.80M |
| Float | 32.01M |
| Short % of Float | +8.10% |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Leadership (GRDN)
Guardian Pharmacy Services, Inc. is led by Fred P. Burke (age 75), CEO, President & Director, per Nexqual as of September 8, 2026 at 07:34 UTC.
| CEO, President & Director | Fred P. Burke (age 75) |
|---|---|
| COO & Director | David K. Morris (age 61) |
Major Backers & Investors (GRDN)
Notable institutional backers of Guardian Pharmacy Services, Inc. include FMR, LLC, Wellington Management, T. Rowe Price, according to Nexqual as of September 8, 2026 at 07:34 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 6.51% |
| Wellington Management | 3.47% |
| T. Rowe Price | 2.92% |
| Fidelity | 2.68% |
| Woodline Partners LP | 2.62% |
| Valiant Capital Management, L.P. | 2.38% |
| Boston Partners | 1.98% |
| Franklin Resources, Inc. | 1.94% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 5.47% |
| BlackRock | 4.11% |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
From Guardian Pharmacy Services, Inc.'s Latest SEC 10-K Filing (filed 2026-03-11)
Key Strengths & Strategy (as disclosed to the SEC)
- Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
- The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.
- Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.
- Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CON | Concentra Group Holdings Parent | USD 34.47 | ▲ 1.29% |
| ARDT | Ardent Health, Inc. | USD 10.91 | ▲ 0% |
| PACS | PACS Group, Inc. | USD 42.5 | ▼ 1.37% |
| BTSG | BrightSpring Health Services, I | USD 60.73 | ▲ 0.8% |
| BKV | BKV Corporation | USD 26.06 | ▲ 3.74% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:34 UTC. This page is informational and not investment advice.